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Partial splenic embolization (PSE) was introduced as an alternative to splenectomy to 
avoid the risk of post-splenectomy sepsis and to reduce the number of situations in 
which surgery would be dangerous or not feasible [5]. PSE is an accepted therapy for 
the treatment of secondary hypersplenism in various disorders, including oesophageal 
variceal haemorrhage [3], thalassaemia major [5], portal hypertension [1], painful 
splenomegaly [2], Gaucher disease [9], hypersplenism in cirrhosis [5], and prior to 
myelosuppressive treatment in hepatocarcinoma and active chronic hepatitis [2, 3]. 
 
As an alternative to surgical splenectomy, PSE was performed on a 7-year-old girl with 
hereditary spherocytosis and hypersplenism who initially presented with a haemolytic 
crisis; haemoglobin values of 6.8 g/dl, jaundice and splenomegaly. She needed blood 
transfusions on two occasions due to persistent anaemia, with Hb values between 6.8-9 
g/dl. PSE was performed following the Spigos protocol [8]. 
 
Peripheral blood cell counts were repeated on days 1, 3, 7 and 15, and then 1, 3, 6, and 
12 months after PSE (see Table 1). Abdominal ultrasound 1 month after PSE showed a 
17% reduction in spleen size, with embolization of approximately 75% of the spleen. 
 
Maddison [7] performed the first successful splenic arterial embolization in 1973. The 
procedure was initially associated with significant morbidity and mortality, but 
subsequent series report substantially improved results [6]. We performed the 
embolization technique described by Spigos [1, 3, 6, 8] because it has a very low risk of 
complications, although Israel et al. [5] recently reported a lower rate of complications 
using polyvinyl alcohol. 
 
The increase in haemoglobin values found in our patient has been observed in patients 
affected by other diseases who have required PSE [5]. The thrombocytosis observed in 
our patient during the first 15 days after PSE that returned to normal values over 3 
months, has been previously reported [3, 5]. This increase in platelet count appears to be 
due to the increase in sequestration in the spleen. There were no modifications in the 
white cells. The clinical course in our patient was similar to that described by others [3, 
6], with moderate fever for 3 days, mild abdominal pain and vomiting (known as the 
postembolization syndrome) and alleviated by symptomatic treatment [2]. We did not 
observe any other complications (e.g. pleural effusion, pancreatitis, pneumonia [1]). 
 
We attempted to infarct between 70% and 80% of the splenic parenchyma, as it has 
been clinically and experimentally demonstrated that a 30% remnant of splenic tissue 
can provide protection against infection [4]. 
 
We suggest PSE to be an acceptable alternative to splenectomy in a child with 
hereditary spherocytosis and secondary hypersplenism, owing to the simplicity of the 
technique, the favourable outcome and the absence of complications in our case. 
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 Table 1. Haemoglobin, platelets, leucocytes and total bilirubin 
data before and after PSE 
 
Before 
PSE 
1 day 3 day 7 day 15 day 1 mo 3 mo 6 mo 12 mo 
Haemoglobin (g/dl) 6.8-8 9.1 9.5 10.1 10.5 12.6 12.8 12.5 12.2 
Platelets (10
9
/1) 334 374 420 635 902 571 471 450 436 
Leucocytes (10
9
/1) 7.4 8.0 7.3 7.4 8.1 7.9 7.1 7.2 8.6 
Total bilirubin (mg/dl) 3.4   0.5   0.6  0.1 
 
 
 
 
